ImageProVision had the privilege of participating in DISSO Asia 2025, a premier forum dedicated to dissolution testing, formulation development, and advancing pharmaceutical sciences. The event, held in Jakarta on July 29–30, 2025, brought together global thought leaders, regulators, researchers, and industry professionals to share insights and foster collaboration.
A key highlight of our participation was the presentation delivered by our Founder & CEO, Mr. Sandeep Kulkarni, on the topic:
“Enhancing Dissolution Predictability through AI-Based Particle Morphology Analysis”
In his lecture, Mr. Kulkarni showcased how AI-powered particle morphology analysis—enabled by our CLAIRITY™ Suite—is transforming dissolution testing into a predictive and scalable science. He emphasized how this approach helps bridge in-vitro and in-vivo outcomes, while driving accuracy, efficiency, and regulatory compliance in pharmaceutical workflows.
The session was very well received and was followed by engaging interactions with senior leaders, including:
Dr. Rajeev Raghuvanshi, Drug Controller General of India (DCGI) — exchanging ideas on digital QC transformation and regulatory data integrity.
Prof. Taruna Ikrar, Chairperson, Indonesia FDA (BPOM) — discussing the importance of harmonizing global quality frameworks.
Senior leadership teams from leading pharmaceutical organizations across India and Indonesia — exploring future pathways for analytical excellence through intelligent imaging.
At ImageProVision, we believe innovation thrives when knowledge is shared. Events like DISSO Asia 2025 reaffirm our commitment to empowering the pharma and life science community with automation-first, AI-driven microscopy platforms—designed for accuracy, compliance, and digital traceability from R&D to QC.
